Emmanuel O. Akano - Publications
Affiliations: | 2016- | National Institutes of Health, Bethesda, MD |
Year | Citation | Score | |||
---|---|---|---|---|---|
2020 | Moritz AE, Free RB, Weiner WS, Akano EO, Gandhi D, Abramyan A, Keck TM, Ferrer M, Hu X, Southall N, Steiner J, Aubé J, Shi L, Frankowski KJ, Sibley DR. Discovery, Optimization and Characterization of ML417: A Novel and Highly Selective D3 Dopamine Receptor Agonist. Journal of Medicinal Chemistry. PMID 32342685 DOI: 10.1021/Acs.Jmedchem.0C00424 | 0.547 | |||
2020 | Akano EO, Casazza JA, Dranchak P, Moritz AE, Free RB, Inglese J, Sibley DR. Development of a dopaminergic neurodegeneration assay using laser cytometry of Caenorhabditis elegans models of Parkinson’s disease The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.02481 | 0.517 | |||
2020 | Moritz AE, Inbody LR, Gandhi DM, Akano E, Fearce C, Free RB, Barnaeva ES, Hu X, Southall NT, Ferrer M, Keck TM, Frankowski KJ, Sibley DR. Structure‐Activity Relationships of a Negative Allosteric Modulator of the D3 Dopamine Receptor and Investigation of its Binding Site The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.02441 | 0.542 | |||
Show low-probability matches. |